Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHOTAC: RLP068/Cl Photodynamic Therapy for Moderate-to-Severe Acne Vulgaris
NCT07089368Not yet recruiting
- Sponsor
- University of Brescia
- Start
- Aug 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of RLP068 in acne vulgaris, sponsored by University of Brescia. Primary endpoint: Global Acne Grading System at 6 weeks. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
RLP068
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT07089368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07089368.